These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 19025174)
21. Psychosexual well-being in women using oral contraceptives containing drospirenone. Nappi RE; Albani F; Tonani S; Santamaria V; Pisani C; Terreno E; Martini E; Polatti F Funct Neurol; 2009; 24(2):71-5. PubMed ID: 19775533 [TBL] [Abstract][Full Text] [Related]
22. Extended cycle combined hormonal contraception. Steinauer J; Autry AM Obstet Gynecol Clin North Am; 2007 Mar; 34(1):43-55, viii. PubMed ID: 17472864 [TBL] [Abstract][Full Text] [Related]
23. Preferences for new and existing contraceptive products. Fiebig DG; Knox S; Viney R; Haas M; Street DJ Health Econ; 2011 Sep; 20 Suppl 1():35-52. PubMed ID: 21809412 [TBL] [Abstract][Full Text] [Related]
26. Menstrual function, menstrual suppression, and the immunology of the human female reproductive tract. Howes M Perspect Biol Med; 2010; 53(1):16-30. PubMed ID: 20173293 [TBL] [Abstract][Full Text] [Related]
27. Factors associated with willingness to use the contraceptive vaginal ring. Gilliam M; Holmquist S; Berlin A Contraception; 2007 Jul; 76(1):30-4. PubMed ID: 17586133 [TBL] [Abstract][Full Text] [Related]
28. Bleeding after use of the levonorgestrel regimen of emergency contraception: concordance between women's reports of their menstrual periods and an objective algorithm. Trussell J Contraception; 2007 Jan; 75(1):32-6. PubMed ID: 17161121 [TBL] [Abstract][Full Text] [Related]
30. A survey on Swiss women's preferred menstrual/withdrawal bleeding pattern over different phases of reproductive life and with use of hormonal contraception. Merki-Feld GS; Breitschmid N; Seifert B; Kreft M Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):266-75. PubMed ID: 24856072 [TBL] [Abstract][Full Text] [Related]
31. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic. Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries. Gerlinger C; Endrikat J; Kallischnigg G; Wessel J Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):203-11. PubMed ID: 17763258 [TBL] [Abstract][Full Text] [Related]
34. Trends that will affect your future ... a different kind of woman. Schwartz SA Explore (NY); 2006 May; 2(3):198-9. PubMed ID: 16781641 [No Abstract] [Full Text] [Related]
35. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial. Sulak PJ; Smith V; Coffee A; Witt I; Kuehl AL; Kuehl TJ Obstet Gynecol; 2008 Sep; 112(3):563-71. PubMed ID: 18757653 [TBL] [Abstract][Full Text] [Related]
36. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study. Fleischer K; van Vliet HA; Rosendaal FR; Rosing J; Tchaikovski S; Helmerhorst FM Thromb Res; 2009; 123(3):429-35. PubMed ID: 18829069 [TBL] [Abstract][Full Text] [Related]
37. Extended-regimen contraception: effects on menstrual symptoms and quality of life. Nelson AL J Fam Pract; 2006 Feb; 55(2):S1-8. PubMed ID: 16451775 [No Abstract] [Full Text] [Related]
38. First-year contraceptive failure rate is substantially above target for 2010. Hollander D Perspect Sex Reprod Health; 2008 Jun; 40(2):118-9. PubMed ID: 18577145 [No Abstract] [Full Text] [Related]